{"changeSha256":"c4d0c748565fec498993f2648028f5c0edae12d6e803c0d7a5a2bca793fcf121","changedAt":"2026-11-15","changedFields":[{"after":"PeptideScanner retained ClinicalTrials.gov record NCT03150511 at 2026-11-15T19:17:31.036Z. Its registry update date was 2026-11-09, and PeptideScanner's reviewed identity mapping was tesamorelin.","before":"PeptideScanner retained ClinicalTrials.gov record NCT03150511 at 2026-07-30T18:19:48.216Z. Its registry update date was 2025-11-12, and PeptideScanner's reviewed identity mapping was tesamorelin.","field":"Summary"},{"after":"2026-11-09","before":"2025-11-12","field":"Cited source date"},{"after":"2026-11-15","before":"2026-07-30","field":"Source observed date"},{"after":"ctg-observation-nct03150511-2025-11-12-65e14fe63370-r2","before":"ctg-observation-nct03150511-2025-11-12-65e14fe63370","field":"Cited source records"},{"after":"ctg-observation-nct03150511-2025-11-12-65e14fe63370-r2","before":"ctg-observation-nct03150511-2025-11-12-65e14fe63370","field":"Headline citations"},{"after":"ctg-observation-nct03150511-2025-11-12-65e14fe63370-r2","before":"ctg-observation-nct03150511-2025-11-12-65e14fe63370","field":"Summary citations"},{"after":"1. PeptideScanner retained ClinicalTrials.gov record NCT03150511 at 2026-11-15T19:17:31.036Z. Its registry update date was 2026-11-09, and PeptideScanner's reviewed identity mapping was tesamorelin. [sources: ctg-observation-nct03150511-2025-11-12-65e14fe63370-r2]\n2. This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. [sources: ctg-observation-nct03150511-2025-11-12-65e14fe63370-r2]","before":"1. PeptideScanner retained ClinicalTrials.gov record NCT03150511 at 2026-07-30T18:19:48.216Z. Its registry update date was 2025-11-12, and PeptideScanner's reviewed identity mapping was tesamorelin. [sources: ctg-observation-nct03150511-2025-11-12-65e14fe63370]\n2. This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. [sources: ctg-observation-nct03150511-2025-11-12-65e14fe63370]","field":"Attributable context"},{"after":"6580b5c21253335cfed5de2cdba5235532b58332c3edabaec07b275de27592e7","before":"162498e56569aa7d626e3b59278dc3ecd3ba8322886eb40af608461e04ae085b","field":"Source snapshot commitment"}],"currentVersion":{"canonicalUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct03150511-tesamorelin/#version-2","version":2},"id":"story:clinicaltrials-gov-nct03150511-tesamorelin:v2","interpretationBoundary":"This event describes a PeptideScanner public-version change. It does not by itself establish that the cited source changed, that a scientific conclusion changed, or that source monitoring is continuous.","kind":"record-updated","notice":"ClinicalTrials.gov posted a newer version of NCT03150511, with a registry update date of 2026-11-09. This version reports that observation; the earlier retained observation remains available as version 1.","peptideSlugs":["tesamorelin"],"previousChangeEvent":null,"previousVersion":{"canonicalUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct03150511-tesamorelin/#version-1","version":1},"schemaVersion":"peptidescanner-public-correction-lineage-event/v1","sourceRecords":[{"id":"ctg-observation-nct03150511-2025-11-12-65e14fe63370-r2","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT03150511 · retained source version 2026-11-09:9098411ceb32fcb7f450cbc2816eb0995a62ef02bd91f6c02e43d6e3c9b5ae59","url":"https://clinicaltrials.gov/study/NCT03150511","verifiedAt":"2026-11-15"}],"subject":{"slug":"clinicaltrials-gov-nct03150511-tesamorelin","type":"story"}}
